STAT Plus 7 things to know about Aimmunes peanut allergy therapy ahead of a pivotal FDA meeting

STAT Plus: 7 things to know about Aimmune’s peanut allergy therapy ahead of a pivotal FDA meeting

04:35 EDT 4 Sep 2019 | STAT

Ahead of a pivotal FDA meeting, here are seven things to know about Aimmune’s peanut allergy therapy.

More From BioPortfolio on "STAT Plus: 7 things to know about Aimmune’s peanut allergy therapy ahead of a pivotal FDA meeting"